IRSF believes that research into a variety of Rett and Rett-related topics is necessary to create treatments and eventual cures for every individual living with Rett syndrome. We proudly invest in such research at every stage: from basic science that can change the way we think about MeCP2 to clinical research that directly impacts potential treatments. We also help connect Rett researchers with external funding opportunities.
rom the generous support of our donors, we provide funding through two different grant mechanisms:
- Innovation Award
- Required Letter of intent due: May 20, 2022, at 5 pm ET
- Full application due: July 1, 2022, at 5 pm ET
- Independence Award
- Required Letter of intent due: May 20, 2022, at 5 pm ET
- Full application due: July 1, 2022, at 5 pm ET